Market Insights
Elastomeric infusion pumps are disposable medical devices used for the administration of liquid drugs such as analgesics, antibiotics, chemotherapy medications, etc. The rise in the adoption of elastomeric pumps is attributed to driving factors such as growth in demand for disposable ambulatory pumps, rising preference for long-term home healthcare, growing hospitalization rates, and evolving reimbursement policies.
The report titled “Global Elastomeric Infusion Pumps Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall elastomeric infusion pumps market, along with the market size and estimates for the duration of 2017–2025. The research study covers an in-depth analysis of market segments based on pump type, application, usage area, and different geographical regions.
The report also includes sections on the competitive profiling of the leading players in the global elastomeric infusion pumps market, attractive investment propositions, and market positioning of key manufacturers to assist strategic decision-makers.
Geographically, the global elastomeric infusion pumps market is studied for the following regional markets:
- North America
- Europe
- Germany
- France
- Italy
- U.K.
- Russia
- Rest of Europe
- Asia-Pacific
- India
- China
- Japan
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa
The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global elastomeric infusion pumps market.
Tools such as key player market positioning and appealing investment propositions provide readers with insights into the competitive landscape of the global elastomeric infusion pumps market. This report concludes with a company profiles section that highlights major information about the key players engaged in the global elastomeric infusion pumps market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report.
Thus, the research study provides a holistic view of the global elastomeric infusion pumps market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.
Based on the type of pumps, the elastomeric infusion pumps market is segmented as follows:
- Continuous-rate pumps
- Variable-rate pumps
Elastomeric infusion pumps are non-electric medication pumps that are used to deliver fluids such as analgesics, antibiotics, cytostatics, and anesthetics. It was observed that elastomeric infusion pumps had gained wide acceptance to provide postoperative analgesia in recent years. A few published studies suggested that patients are shifting towards elastomeric devices rather than electronic pumps due to their low weight and size, user-friendly nature, and less sleep interference. These infusion pumps are calibrated under various conditions such as fluid viscosity, operating temperature and pressure, backpressure, and the recommended time between filling the device and starting the infusion.
The two major types of elastomeric infusion pumps are continuous rate pumps and variable rate pumps, of which continuous rate pumps accounted for the largest market share in 2016. The key factors driving the continuous rate pump market are their widespread application in treatment, the fact that products have evolved over time and now provide efficient performance, and their growing application in cancer treatment. However, during the forecast period of 2017–2025, variable rate pumps were observed as the fastest-growing segment in the overall market.
Based on the types of applications, the elastomeric infusion pumps market is segmented as follows:
- Pain Management (Anesthetics and Analgesics)
- Infection Management (Antibiotics and Antivirals)
- Cytostatic Treatment
- Others (Chelation, for example)
Elastomeric infusion pumps are used to administer medication in a controlled manner into the patient’s body. It has an advantage in terms of being easy to use, portable, and mobile, and it also facilitates accuracy, a high level of control, and precision in drug delivery, thus avoiding errors in medication dosage. Elastomeric infusion pumps are used to administer analgesics, anti-infectives, anesthetics, cytostatics, or antibiotics (depending on the therapy). Thus, it has applications for pain management, infection management, cytostatic treatment, and chelation therapy.
The major application of an infusion pump is postoperative analgesia for pain management. Pain management occupies the largest share in the application segment of the elastomeric infusion market. Elastomeric infusion pumps are designed to deliver anesthetics and analgesics to a lesion or inflamed tissue. It acts as a superior analgesic, and fewer complications are observed compared to opioid dosage. Cytostatic treatment was the second-largest segment because infusion pump therapy is more effective and well-tolerated in cancer patients.
Based on the type of usage area, the elastomeric infusion pumps market is segmented as follows:
- Hospitals and Clinics
- Ambulatory Care
- Home Care
Elastomeric infusion pumps are non-electric medication pumps that are used to deliver fluids such as analgesics, antibiotics, cytostatics, and anesthetics. Based on the types of usage areas, the global elastomeric infusion pump market is segmented into hospitals and clinics, ambulatory care centers, and home care. Among the considered usage areas, hospitals and clinics currently dominate the global elastomeric infusion pump market. Higher affordability, greater awareness among hospital staff, and the potential of an elastomeric infusion pump to reduce manpower and treatment costs in the long run greatly contribute to the dominance of hospitals and clinics in the market.
Furthermore, better reimbursement policies and a growing preference for home care in order to save treatment costs have led to rapid market growth in the home care segment during the forecast period. The most appealing usage area segments for elastomeric infusion pumps are observed to be ambulatory care and home care settings. The growing preference for home care for chronic disease management, as well as the resulting cost savings in healthcare, all contribute significantly to the emergence of the home care segment.
For the purpose of this study, the global elastomeric infusion pumps market is categorized into:
- North America
- Europe
- Asia Pacific
- Latin America (LATAM)
- Middle East and Africa (MEA)
For the purpose of this study, the global elastomeric infusion pumps market is categorized into six regional markets: North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. In the base year 2016, North America was observed as the largest market for elastomeric infusion pumps, followed by Europe. In North America and Europe, there is an increase in chronic diseases like gastrointestinal complications, abdominal hernias, etc. According to the Agency for Healthcare Research and Quality, there were 36.5 million hospital stays in the United States in 2012, with an average length of stay of 4.5 days and a cost of US$ 10,400 per stay.
The high rate of hospitalization has increased the number of surgeries, which has had a positive impact on the growth of the market for elastomeric infusion pumps. Asia-Pacific, the Middle East, and Africa are potential markets due to the high prevalence of chronic diseases requiring surgical procedures but low disease awareness. According to OECD Health Data 2012, China, Malaysia, and Japan were the three top Asian countries where around 120–135 patients per 1,000 people were discharged after an overnight stay or more in the hospital.
